Only 85 patients initially for pivotal ph 3 FSGS. Sophisticated investors will be throwing funds at DXB, IMO.
Ann: Positive Additional Data to Support DMX-200 Development, page-10
-
- There are more pages in this discussion • 109 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add DXB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
38.0¢ |
Change
-0.005(1.30%) |
Mkt cap ! $217.2M | |||
| Open | High | Low | Value | Volume |
| 38.5¢ | 39.3¢ | 38.0¢ | $350.2K | 902.6K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 5 | 45654 | 38.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 38.5¢ | 33188 | 7 |
View Market Depth
| Last trade - 11.46am 30/09/2024 (20 minute delay) ? |
| DXB (ASX) Chart |